Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients

To evaluate the clinical and immunologic outcomes of DC (dendritic cell) vaccine with interleukin (IL)-2 and IFN-alpha 2a in metastatic renal cell carcinoma patients.


Published in:
Clinical cancer research : an official journal of the American Association for Cancer Research, 15, 15, 4986-92
Year:
2009
Publisher:
American Association for Cancer Research
ISSN:
1078-0432
Laboratories:




 Record created 2012-11-05, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)